INmune Bio Inc
NASDAQ:INMB
INmune Bio Inc
NASDAQ:INMB
Price:
1.42
USD
2.16%
Market Closed
Market Cap:
$37.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
INmune Bio Inc
NASDAQ:INMB
|
US |
|
Ambev SA
NYSE:ABEV
|
BR |
|
S
|
Springer Nature AG & Co KgaA
F:SPG
|
DE |
|
W
|
Westport Fuel Systems Inc
XBER:WPIA
|
CA |
|
A
|
Adidas AG
MIL:ADS
|
DE |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
|
R
|
RealNetworks Inc
F:RNWA
|
US |
|
CIMIC Group Ltd
ASX:CIM
|
AU |
|
Renault SA
PAR:RNO
|
FR |
|
Chimerix Inc
NASDAQ:CMRX
|
US |
|
Malibu Boats Inc
NASDAQ:MBUU
|
US |
|
Metso Outotec Corp
OTC:OUKPY
|
FI |
|
C
|
Cloudastructure Inc
NASDAQ:CSAI
|
US |
|
Grupo Aeroportuario del Centro Norte SAB de CV
NASDAQ:OMAB
|
MX |
|
Arca Continental SAB de CV
OTC:EMBVF
|
MX |
|
C
|
Campbell Soup Co
F:CSC
|
US |
|
Bank Negara Indonesia (Persero) Tbk PT
OTC:PTBRY
|
ID |
|
Chrysalis Investments Ltd
LSE:CHRY
|
GG |
Wall St Price Targets
INMB Price Targets Summary
INmune Bio Inc
INmune Bio Inc
Wall Street analysts forecast INMB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for INMB is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
Lowest Forecast
Price Target
4.04
USD
185% Upside
Average Forecast
Price Target
7.14
USD
403% Upside
Highest Forecast
Price Target
9.45
USD
565% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INMB's stock price target?
Price Target
7.14
USD
7.14
USD
According to Wall Street analysts, the average 1-year price target for INMB is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for INmune Bio Inc?
Projected CAGR
206%
206%
The compound annual growth rate for Revenue over the next 8 years is 206%.
